- Home
- ZBIO vs LXFR Comparison
ZBIO vs LXFR Comparison
Compare ZBIO & LXFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZBIO
- LXFR
- Stock Information
- Founded
- ZBIO 2019
- LXFR 1898
- Country
- ZBIO United States
- LXFR United States
- Employees
- ZBIO N/A
- LXFR N/A
- Industry
- ZBIO
- LXFR Major Chemicals
- Sector
- ZBIO
- LXFR Industrials
- Exchange
- ZBIO NYSE
- LXFR Nasdaq
- Market Cap
- ZBIO 339.3M
- LXFR 328.4M
- IPO Year
- ZBIO 2024
- LXFR 2012
- Fundamental
- Price
- ZBIO $8.40
- LXFR $14.02
- Analyst Decision
- ZBIO Strong Buy
- LXFR
- Analyst Count
- ZBIO 5
- LXFR 0
- Target Price
- ZBIO $31.75
- LXFR N/A
- AVG Volume (30 Days)
- ZBIO 371.9K
- LXFR 127.9K
- Earning Date
- ZBIO 02-16-2025
- LXFR 02-25-2025
- Dividend Yield
- ZBIO N/A
- LXFR 3.76%
- EPS Growth
- ZBIO N/A
- LXFR 57.96
- EPS
- ZBIO N/A
- LXFR 0.34
- Revenue
- ZBIO N/A
- LXFR $384,400,000.00
- Revenue This Year
- ZBIO N/A
- LXFR N/A
- Revenue Next Year
- ZBIO N/A
- LXFR $3.44
- P/E Ratio
- ZBIO N/A
- LXFR $40.79
- Revenue Growth
- ZBIO N/A
- LXFR N/A
- 52 Week Low
- ZBIO $7.50
- LXFR $7.55
- 52 Week High
- ZBIO $26.25
- LXFR $15.64
- Technical
- Relative Strength Index (RSI)
- ZBIO N/A
- LXFR 60.98
- Support Level
- ZBIO N/A
- LXFR $12.05
- Resistance Level
- ZBIO N/A
- LXFR $13.35
- Average True Range (ATR)
- ZBIO 0.00
- LXFR 0.40
- MACD
- ZBIO 0.00
- LXFR 0.15
- Stochastic Oscillator
- ZBIO 0.00
- LXFR 96.10
About ZBIO ZENAS BIOPHARMA INC
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them.
About LXFR Luxfer Holdings PLC
Luxfer Holdings PLC is a manufacturer industrial company innovating niche applications in materials engineering. It focuses on value creation by using its broad array of technical know-how and proprietary technologies to help create a safe, clean, and energy-efficient world. Luxfer's high-performance materials, components, and high-pressure gas containment devices are used in defense, first response and healthcare, transportation, and general industrial applications. It focuses on product lines related to magnesium alloys, zirconium chemicals, and carbon composites. Its segments are Elektron, Gas Cylinders, and Graphic Arts. It generates the majority of its revenue from Elektron and as well as Gas Cylinders.